Who
In numbers
- Trades disclosed
- 15
- Buys
- 1
- Sells
- 0
- Bought
- $50K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 26 Aug 2021
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 20 May 2024filed 21 May 2024 | HUMA HumacyteBiotechnology | SEC FORM 4 Bought | $25K4,015 at $6.21 | filing |
| 20 May 2024filed 21 May 2024 | HUMA HumacyteBiotechnology | SEC FORM 4 Bought | $25K3,990 at $6.29 | filing |
| 21 Nov 2023filed 21 Nov 2023 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,564 at $0.00 | filing |
| 21 Nov 2023filed 21 Nov 2023 | HUMA HumacyteBiotechnology | SEC FORM 4 Code M | $7,8116,564 at $1.19 | filing |
| 15 Jun 2023filed 16 Jun 2023 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,500 at $0.00 | filing |
| 9 Jun 2022filed 13 Jun 2022 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,500 at $0.00 | filing |
| 13 Oct 2021filed 15 Oct 2021 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,500 at $0.00 | filing |
| 26 Aug 2021filed 27 Aug 2021 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,564 | filing |
| 26 Aug 2021filed 27 Aug 2021 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,129 | filing |
| 26 Aug 2021filed 27 Aug 2021 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,068 | filing |
| 26 Aug 2021filed 27 Aug 2021 | HUMA HumacyteBiotechnology | SEC FORM 4 Code A | —49,986 | filing |
News
Humacyte Provides Commercial Update and Highlights Rapid Acceleration of Symvess Adoption by HospitalsHUMA · manilatimes.net · 15 Oct 2026
0 headlines in the last 90 days name Max N. Wallace; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.